Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Notice of Consultation on the Prescription Drug List (PDL): Brimonidine Date: August 27, 2021 Our file number: 21-115489-476 This Notice of Consultation provides an opportunity to comment on the proposal to revise the listing for brimonidine or its salts, by adding a qualifier to…
Notice: Prescription Drug List (PDL): Multiple Additions Date: September 10, 2021 Our file number: 21-116232-170 The purpose of this Notice of Amendment is to notify about the additions of: Elexacaftor, Inclisiran, Ospemifene, Pralsetinib and Tafasitamab to the Prescription Drug…
Qualifying Notice - Minjuvi Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney’s Pasture, A.L. 0601C Ottawa, Ontario K1A 0K9 Dossier ID: HC6-024-E247025 Control #: 247025 [employee name removed] [employee title remove] Incyte…
Qualifying Notice - Lumakras Therapeutic Products Directorate Holland Cross, Tower "B" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa, Ontario K1A 0K9 Dossier ID: e230960 [employee name removed] [employee's title removed] [name of company removed] Dear [employee name…
Prescription status of edaravone and personal importation: Notice of update Updated: September 29, 2022 As of October 1, 2022, Health Canada will no longer use enforcement discretion to allow the personal import of edaravone (brand name Radicava). This measure is no longer…
Qualifying notice: Pemazyre Therapeutic Products Directorate Holland Cross, Tower "B" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa, Ontario K1A 0K9 Dossier ID: e242569 [employee name removed] [employee title removed] Incyte Corporation 1801 Augustine Cut-Off…
Mid-year update: Health products approved in 2021 Learn about our work to support Canada's response to COVID-19, the new drugs, medical devices, over-the counter and natural health products that Health Canada approved for sale in Canada, as well as clinical information that was…
Qualifying notice: Zepzelca Therapeutic Product Directorate Holland Cross, Tower "B" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa, Ontario K1A 0K9 Dossier ID : e241552 [employee name removed] [employee's title removed] [name of company removed] Dear [employee name…
Notice: Prescription Drug List (PDL): Multiple Additions Date: October 21, 2021 Our file number: 21-118202-165 The purpose of this Notice of Amendment is to notify of the addition of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary…
Scientific Advisory Committee on Health Products for Women (SAC-HPW): Agenda Date and time: October 27, 2021, 11:00am - 5:00 pm EDT Location: via Zoom Chair: Lorraine Greaves (Chair), Louise Pilote (Vice-chair) Secretariat: Jenna Griffiths, Laetitia Guillemette, Therapeutic…
Early release: coverage and features are still expanding.
